Cited by 17

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Expression Analysis of BDNF, BACE1, and Their Natural Occurring Antisenses in Autistic Patients

Ghafouri-Fard, Soudeh, Namvar, Amir, Arsang-Jang, Shahram, Komaki, Alireza, Taheri, Mohammad·2020·Journal of Molecular Neuroscience

Abstract

Autism spectrum disorder (ASD) as a multifaceted neurological syndrome affects many aspects of neuropsychologic functions. Dysregulated expressions of several genes have been documented in ASD patients. The current project aimed at comparison of transcript levels of brain derived neurotrophic factor (BDNF), beta-site amyloid precursor protein cleaving enzyme 1 (BACE1), and their natural occurring antisenses in the peripheral blood of ASD individuals (n = 50, male/female = 38/12, age (mean ± standard deviation (SD)): 6 ± 1.4, age range: 3-8) and matched healthy persons (n = 50, male/female = 37/13, age (mean ± SD): 6 ± 1.74, age range: 3-8). We demonstrated remarkable higher levels of these genes in ASD patients. BACE1 transcript levels were correlated with transcript levels of BACE1-AS in all study participants. However, BACE1 transcript levels were not correlated with participants' age. BACE1-AS and BDNF transcript levels were correlated with age in female participants. Significant correlations were detected between transcript levels of BDNF and those of other genes in all study groups. The current results render further indications for contribution of BDNF, BACE1, and their antisenses in the course of ASD and suggested expression levels of these transcripts as putative markers for this neurobehavioral disorder. Such results might be applied in clinical setting for diagnosis of complicated ASD cases.

Overview

Integrity signals

Registry

Crossref · 10.1007/s12031-019-01432-7

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The lncRNA species BACE1-AS strongly correlates with BACE1 expression and is measurable in human plasma samples, with levels increased in patients with AD and autism.

    “The lncRNA species BACE1‐AS strongly correlates with BACE1 expression and is also measurable in human plasma samples, with levels increased in patients with AD 193 and autism.”

    From BACE1: More than just a β‐secretase (2022) · cites this paper as [194]

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 24

  1. Agilli M, Aydin FN, Cayci T, Kurt YG (2015) Methodological approach to brain derived neurotrophic factor in children with autism spectrum disorder. Ann Neurosci 22(4):250–250. https://doi.org/10.5214/ans.0972.7531.220416 · DOI
  2. Bailey AR, Giunta BN, Obregon D, Nikolic WV, Tian J, Sanberg CD, Tan J (2008) Peripheral biomarkers in autism: secreted amyloid precursor protein-alpha as a probable key player in early diagnosis. Int J Clin Exp Med 1(4):338–344
  3. Broek, J. A. C., Guest, P. C., Rahmoune, H., & Bahn, S. (2014). Proteomic analysis of post mortem brain tissue from autism patients: evidence for opposite changes in prefrontal cortex and cerebellum in synaptic connectivity-related proteins. Mol Autism, 5. doi: Artn 41 https://doi.org/10.1186/2040-2392-5-41 · DOI
  4. Bryn V, Halvorsen B, Ueland T, Isaksen J, Kolkova K, Ravn K, Skjeldal OH (2015) Brain derived neurotrophic factor (BDNF) and autism spectrum disorders (ASD) in childhood. Eur J Paediatr Neurol 19(4):411–414. https://doi.org/10.1016/j.ejpn.2015.03.005 · DOI · Paper page
  5. Dianatpour A, Ghafouri-Fard S (2017) The role of long non coding rnas in the repair of dna double strand breaks. Int J Mol Cell Med 6(1):1–12
  6. Dorahy MJ (2014) The diagnostic and statistical manual of mental disorders–5th edition (DSM-5)
  7. Huerta M, Lord C (2012) Diagnostic evaluation of autism spectrum disorders. Pediatric Clin N Am 59(1):103. https://doi.org/10.1016/j.pcl.2011.10.018 · DOI
  8. Kamikubo Y, Takasugi N, Niisato K, Hashimoto Y, Sakurai T (2017) Consecutive analysis of BACE1 function on developing and developed neuronal cells. J Alzheimers Dis 56(2):641–653. https://doi.org/10.3233/jad-160806 · DOI
  9. Kasarpalkar NJ, Kothari ST, Dave UP (2014) Brain-derived neurotrophic factor in children with autism spectrum disorder. Ann Neurosci 21(4):129–133. https://doi.org/10.5214/ans.0972.7531.210403 · DOI
  10. Kong SW, Shimizu-Motohashi Y, Campbell MG, Lee IH, Collins CD, Brewster SJ, Kunkel LM (2013) Peripheral blood gene expression signature differentiates children with autism from unaffected siblings. Neurogenetics 14(2):143–152. https://doi.org/10.1007/s10048-013-0363-z · DOI
  11. Lahiri DK, Sokol DK, Erickson C, Ray B, Ho CY, Maloney B (2013) Autism as early neurodevelopmental disorder: evidence for an sAPPα-mediated anabolic pathway. Front Cell Neurosci:7 · DOI
  12. Lainhart JE, Lange N (2011) Increased neuron number and head size in autism. JAMA 306(18):2031–2032. https://doi.org/10.1001/jama.2011.1633 · DOI
  13. Nieto R, Kukuljan M, Silva H (2013) BDNF and schizophrenia: from neurodevelopment to neuronal plasticity, learning, and memory. Front Psychiatry 4:45. https://doi.org/10.3389/fpsyt.2013.00045 · DOI
  14. Purcell AE, Jeon OH, Zimmerman AW, Pevsner J (2001) Postmortem brain abnormalities of the glutamate neurotransmitter system in autism. Neurology 57(9):1618–1628. https://doi.org/10.1212/Wnl.57.9.1618 · DOI · Paper page
  15. Ray B, Long JM, Sokol DK, Lahiri DK (2011) Increased secreted amyloid precursor protein-alpha (sAPPalpha) in severe autism: proposal of a specific, anabolic pathway and putative biomarker. PLoS One 6(6):e20405. https://doi.org/10.1371/journal.pone.0020405 · DOI
  16. Rollins B, Martin MV, Morgan L, Vawter MP (2010) Analysis of whole genome biomarker expression in blood and brain. Am J Med Genet B Neuropsychiatr Genet 153B(4):919–936. https://doi.org/10.1002/ajmg.b.31062 · DOI
  17. Shim SH, Hwangbo Y, Kwon YJ, Jeong HY, Lee BH, Lee HJ, Kim YK (2008) Increased levels of plasma brain-derived neurotrophic factor (BDNF) in children with attention deficit-hyperactivity disorder (ADHD). Prog Neuro-Psychopharmacol Biol Psychiatry 32(8):1824–1828. https://doi.org/10.1016/j.pnpbp.2008.08.005 · DOI · Paper page
  18. Sokol DK, Chen DM, Farlow MR, Dunn DW, Maloney B, Zimmer JA, Lahiri DK (2006) High levels of Alzheimer beta-amyloid precursor protein (APP) in children with severely autistic behavior and aggression. J Child Neurol 21(6):444–449. https://doi.org/10.2310/7010.2006.00130 · DOI
  19. Tylee DS, Hess JL, Quinn TP, Barve R, Huang H, Zhang-James Y, Glatt SJ (2017) Blood transcriptomic comparison of individuals with and without autism spectrum disorder: a combined-samples mega-analysis. Am J Med Genet B Neuropsychiatr Genet 174(3):181–201. https://doi.org/10.1002/ajmg.b.32511 · DOI
  20. Wang, Y., Zhao, X., Ju, W., Flory, M., Zhong, J., Jiang, S., Wang P, Dong X, Tao X, Chen Q, Shen C, Zhong M, Yu Y, Brown WT Zhong, N. (2015). Genome-wide differential expression of synaptic long noncoding RNAs in autism spectrum disorder. Transl Psychiatry, 5. doi: ARTN e660 https://doi.org/10.1038/tp.2015.144 · DOI
  21. Wilkinson B, Campbell DB (2013) Contribution of long noncoding RNAs to autism spectrum disorder risk. Int Rev Neurobiol 113:35–59. https://doi.org/10.1016/b978-0-12-418700-9.00002-2 · DOI
  22. Zheng Z, Zhang L, Zhu T, Huang J, Qu Y, Mu D (2016) Peripheral brain-derived neurotrophic factor in autism spectrum disorder: a systematic review and meta-analysis. Sci Rep:6 · DOI
  23. Ziats MN, Rennert OM (2013) Aberrant expression of long noncoding RNAs in autistic brain. J Mol Neurosci 49(3):589–593. https://doi.org/10.1007/s12031-012-9880-8 · DOI
  24. Zuo L, Tan Y, Wang Z, Wang KS, Zhang X, Chen X, Li CS, Wang T, Luo X (2016) Long noncoding RNAs in psychiatric disorders. Psychiatr Genet 26(3):109–116. https://doi.org/10.1097/ypg.0000000000000129 · DOI

Cited by

Sorted by citations

Metadata

Authors
Ghafouri-Fard, S., Namvar, A., Arsang-Jang, S., Komaki, A., & Taheri, M.
Venue
Journal of Molecular Neuroscience
Published
2019-11-23
Volume
70
Issue
2
Pages
194-200
ISSN
  • 0895-8696
  • 1559-1166
Cited by
17
References
3
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review